Anticancer activity of cardiac glycosides

The secret ally: immunostimulation by anticancer drugs

(2012) Lorenzo Galluzzi et al.   NATURE REVIEWS DRUG DISCOVERY

Cardiac Glycosides Exert Anticancer Effects by Inducing Immunogenic Cell Death

(2012) L. Menger et al.   Science Translational Medicine

Trial watch

(2012) Erika Vacchelli et al.   OncoImmunology

Digoxin Use and the Risk of Breast Cancer in Women

(2011) Robert J. Biggar et al.   JOURNAL OF CLINICAL ONCOLOGY

Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity

(2011) Jun R. Huh et al.   NATURE

Antineoplastic activity of ouabain and pyrithione zinc in acute myeloid leukemia

(2011) M Tailler et al.   ONCOGENE

A Novel Two-Stage, Transdisciplinary Study Identifies Digoxin as a Possible Drug for Prostate Cancer Treatment

(2011) Elizabeth A. Platz et al.   Cancer Discovery

Decoding Cell Death Signals in Inflammation and Immunity

(2010) Laurence Zitvogel et al.   CELL

Cardiac glycosides are potent inhibitors of interferon-β gene expression

(2010) Junqiang Ye et al.   Nature Chemical Biology

Cardiac Glycosides Induce Cell Death in Human Cells by Inhibiting General Protein Synthesis

(2009) Andrea Perne et al.   PLoS One

Cardiac Glycosides as Novel Cancer Therapeutic Agents

(2008) R. A. Newman et al.   MOLECULAR INTERVENTIONS